Fusion Gene Studies
in Kim Lab

FusionBase FusionGDB FusionGDB2 FusionPDB FusionNeoAntigen FusionAI FusionNW FGviewer Publication Contact
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:COL4A1-ZNF827 (FusionGDB2 ID:HG1282TG152485)

Fusion Gene Summary for COL4A1-ZNF827

check button Fusion gene summary
Fusion gene informationFusion gene name: COL4A1-ZNF827
Fusion gene ID: hg1282tg152485
HgeneTgene
Gene symbol

COL4A1

ZNF827

Gene ID

1282

152485

Gene namecollagen type IV alpha 1 chainzinc finger protein 827
SynonymsBSVD|BSVD1|PADMAL|RATOR-
Cytomap('COL4A1')('ZNF827')

13q34

4q31.21-q31.22

Type of geneprotein-codingprotein-coding
Descriptioncollagen alpha-1(IV) chainCOL4A1 NC1 domainarrestencollagen IV, alpha-1 polypeptidecollagen of basement membrane, alpha-1 chainzinc finger protein 827
Modification date2020031320200313
UniProtAcc

P02462

.
Ensembl transtripts involved in fusion geneENST00000375820, ENST00000467182, 
ENST00000543140, 
Fusion gene scores* DoF score13 X 15 X 8=156011 X 4 X 7=308
# samples 1511
** MAII scorelog2(15/1560*10)=-3.37851162325373
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(11/308*10)=-1.48542682717024
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: COL4A1 [Title/Abstract] AND ZNF827 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointCOL4A1(110801311)-ZNF827(146859787), # samples:1
Anticipated loss of major functional domain due to fusion event.COL4A1-ZNF827 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
COL4A1-ZNF827 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID

check buttonFusion gene breakpoints across COL4A1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure
check buttonFusion gene breakpoints across ZNF827 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check button Fusion gene information
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4KIRCTCGA-BP-4986-01ACOL4A1chr13

110801311

-ZNF827chr4

146859787

-


Top

Fusion Gene ORF analysis for COL4A1-ZNF827

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
5CDS-intronENST00000375820ENST00000379448COL4A1chr13

110801311

-ZNF827chr4

146859787

-
5CDS-intronENST00000375820ENST00000511534COL4A1chr13

110801311

-ZNF827chr4

146859787

-
5CDS-intronENST00000375820ENST00000513320COL4A1chr13

110801311

-ZNF827chr4

146859787

-
In-frameENST00000375820ENST00000508784COL4A1chr13

110801311

-ZNF827chr4

146859787

-
intron-3CDSENST00000467182ENST00000508784COL4A1chr13

110801311

-ZNF827chr4

146859787

-
intron-3CDSENST00000543140ENST00000508784COL4A1chr13

110801311

-ZNF827chr4

146859787

-
intron-intronENST00000467182ENST00000379448COL4A1chr13

110801311

-ZNF827chr4

146859787

-
intron-intronENST00000467182ENST00000511534COL4A1chr13

110801311

-ZNF827chr4

146859787

-
intron-intronENST00000467182ENST00000513320COL4A1chr13

110801311

-ZNF827chr4

146859787

-
intron-intronENST00000543140ENST00000379448COL4A1chr13

110801311

-ZNF827chr4

146859787

-
intron-intronENST00000543140ENST00000511534COL4A1chr13

110801311

-ZNF827chr4

146859787

-
intron-intronENST00000543140ENST00000513320COL4A1chr13

110801311

-ZNF827chr4

146859787

-

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)
ENST00000375820COL4A1chr13110801311-ENST00000508784ZNF827chr4146859787-1398765246251311689

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000375820ENST00000508784COL4A1chr13110801311-ZNF827chr4146859787-0.0005975750.9994024

Top

Fusion Genomic Features for COL4A1-ZNF827


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.
genomic feature

Top

Fusion Protein Features for COL4A1-ZNF827


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr13:110801311/chr4:146859787)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
COL4A1

P02462

.
FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. {ECO:0000250|UniProtKB:P02463}.; FUNCTION: Arresten, comprising the C-terminal NC1 domain, inhibits angiogenesis and tumor formation. The C-terminal half is found to possess the anti-angiogenic activity. Specifically inhibits endothelial cell proliferation, migration and tube formation. {ECO:0000269|PubMed:10811134, ECO:0000269|PubMed:18775695}.FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneCOL4A1chr13:110801311chr4:146859787ENST00000375820-52521445_166921341670.0DomainCollagen IV NC1
HgeneCOL4A1chr13:110801311chr4:146859787ENST00000375820-5252173_144021341670.0RegionNote=Triple-helical region
TgeneZNF827chr13:110801311chr4:146859787ENST00000379448015311_3540995.0Compositional biasNote=Pro-rich
TgeneZNF827chr13:110801311chr4:146859787ENST00000379448015961_9720995.0Compositional biasNote=Poly-Ser
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-115311_354141976.6666666666667Compositional biasNote=Pro-rich
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-115961_972141976.6666666666667Compositional biasNote=Poly-Ser
TgeneZNF827chr13:110801311chr4:146859787ENST000003794480151019_10410995.0Zinc fingerC2H2-type 8
TgeneZNF827chr13:110801311chr4:146859787ENST000003794480151047_10690995.0Zinc fingerC2H2-type 9
TgeneZNF827chr13:110801311chr4:146859787ENST00000379448015374_3960995.0Zinc fingerC2H2-type 1
TgeneZNF827chr13:110801311chr4:146859787ENST00000379448015402_4240995.0Zinc fingerC2H2-type 2
TgeneZNF827chr13:110801311chr4:146859787ENST00000379448015433_4550995.0Zinc fingerC2H2-type 3
TgeneZNF827chr13:110801311chr4:146859787ENST00000379448015817_8390995.0Zinc fingerC2H2-type 4
TgeneZNF827chr13:110801311chr4:146859787ENST00000379448015845_8670995.0Zinc fingerC2H2-type 5
TgeneZNF827chr13:110801311chr4:146859787ENST00000379448015897_9190995.0Zinc fingerC2H2-type 6
TgeneZNF827chr13:110801311chr4:146859787ENST00000379448015929_9520995.0Zinc fingerC2H2-type 7
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-1151019_1041141976.6666666666667Zinc fingerC2H2-type 8
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-1151047_1069141976.6666666666667Zinc fingerC2H2-type 9
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-115374_396141976.6666666666667Zinc fingerC2H2-type 1
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-115402_424141976.6666666666667Zinc fingerC2H2-type 2
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-115433_455141976.6666666666667Zinc fingerC2H2-type 3
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-115817_839141976.6666666666667Zinc fingerC2H2-type 4
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-115845_867141976.6666666666667Zinc fingerC2H2-type 5
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-115897_919141976.6666666666667Zinc fingerC2H2-type 6
TgeneZNF827chr13:110801311chr4:146859787ENST00000508784-115929_952141976.6666666666667Zinc fingerC2H2-type 7

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for COL4A1-ZNF827


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.
>18348_18348_1_COL4A1-ZNF827_COL4A1_chr13_110801311_ENST00000375820_ZNF827_chr4_146859787_ENST00000508784_length(transcript)=13987nt_BP=6524nt
GCTTGGAGCCGCCGCACCCGGGACGGTGCGTAGCGCTGGAAGTCCGGCCTTCCGAGAGCTAGCTGTCCGCCGCGGCCCCCGCACGCCGGG
CAGCCGTCCCTCGCCGCCTCGGGCGCGCCACCATGGGGCCCCGGCTCAGCGTCTGGCTGCTGCTGCTGCCCGCCGCCCTTCTGCTCCACG
AGGAGCACAGCCGGGCCGCTGCGAAGGGTGGCTGTGCTGGCTCTGGCTGTGGCAAATGTGACTGCCATGGAGTGAAGGGACAAAAGGGTG
AAAGAGGCCTCCCGGGGTTACAAGGTGTCATTGGGTTTCCTGGAATGCAAGGACCTGAGGGGCCACAGGGACCACCAGGACAAAAGGGTG
ATACTGGAGAACCAGGACTACCTGGAACAAAAGGGACAAGAGGACCTCCGGGAGCATCTGGCTACCCTGGAAACCCAGGACTTCCCGGAA
TTCCTGGCCAAGACGGCCCGCCAGGCCCCCCAGGTATTCCAGGATGCAATGGCACAAAGGGGGAGAGAGGGCCGCTCGGGCCTCCTGGCT
TGCCTGGTTTCGCTGGAAATCCCGGACCACCAGGCTTACCAGGGATGAAGGGTGATCCAGGTGAGATACTTGGCCATGTGCCCGGGATGC
TGTTGAAAGGTGAAAGAGGATTTCCCGGAATCCCAGGGACTCCAGGCCCACCAGGACTGCCAGGGCTTCAAGGTCCTGTTGGGCCTCCAG
GATTTACCGGACCACCAGGTCCCCCAGGCCCTCCCGGCCCTCCAGGTGAAAAGGGACAAATGGGCTTAAGTTTTCAAGGACCAAAAGGTG
ACAAGGGTGACCAAGGGGTCAGTGGGCCTCCAGGAGTACCAGGACAAGCTCAAGTTCAAGAAAAAGGAGACTTCGCCACCAAGGGAGAAA
AGGGCCAAAAAGGTGAACCTGGATTTCAGGGGATGCCAGGGGTCGGAGAGAAAGGTGAACCCGGAAAACCAGGACCCAGAGGCAAACCCG
GAAAAGATGGTGACAAAGGGGAAAAAGGGAGTCCCGGTTTTCCTGGTGAACCCGGGTACCCAGGACTCATAGGCCGCCAGGGCCCGCAGG
GAGAAAAGGGTGAAGCAGGTCCTCCTGGCCCACCTGGAATTGTTATAGGCACAGGACCTTTGGGAGAAAAAGGAGAGAGGGGCTACCCTG
GAACTCCGGGGCCAAGAGGAGAGCCAGGCCCAAAAGGTTTCCCAGGACTACCAGGCCAACCCGGACCTCCAGGCCTCCCTGTACCTGGGC
AGGCTGGTGCCCCTGGCTTCCCTGGTGAAAGAGGAGAAAAAGGTGACCGAGGATTTCCTGGTACATCTCTGCCAGGACCAAGTGGAAGAG
ATGGGCTCCCGGGTCCTCCTGGTTCCCCTGGGCCCCCTGGGCAGCCTGGCTACACAAATGGAATTGTGGAATGTCAGCCCGGACCTCCAG
GTGACCAGGGTCCTCCTGGAATTCCAGGGCAGCCAGGATTTATAGGCGAAATTGGAGAGAAAGGTCAAAAAGGAGAGAGTTGCCTCATCT
GTGATATAGACGGATATCGGGGGCCTCCCGGGCCACAGGGACCCCCGGGAGAAATAGGTTTCCCAGGGCAGCCAGGGGCCAAGGGCGACA
GAGGTTTGCCTGGCAGAGATGGTGTTGCAGGAGTGCCAGGCCCTCAAGGTACACCAGGGCTGATAGGCCAGCCAGGAGCCAAGGGGGAGC
CTGGTGAGTTTTATTTCGACTTGCGGCTCAAAGGTGACAAAGGAGACCCAGGCTTTCCAGGACAGCCCGGCATGACAGGGAGAGCGGGTT
CTCCTGGAAGAGATGGCCATCCGGGTCTTCCTGGCCCCAAGGGCTCGCCGGGTTCTGTAGGATTGAAAGGAGAGCGTGGCCCCCCTGGAG
GAGTTGGATTCCCAGGCAGTCGTGGTGACACCGGCCCCCCTGGGCCTCCAGGATATGGTCCTGCTGGTCCCATTGGTGACAAAGGACAAG
CAGGCTTTCCTGGAGGCCCTGGATCCCCAGGCCTGCCAGGTCCAAAGGGTGAACCAGGAAAAATTGTTCCTTTACCAGGCCCCCCTGGAG
CAGAAGGACTGCCGGGGTCCCCAGGCTTCCCAGGTCCCCAAGGAGACCGAGGCTTTCCCGGAACCCCAGGAAGGCCAGGCCTGCCAGGAG
AGAAGGGCGCTGTGGGCCAGCCAGGCATTGGATTTCCAGGGCCCCCCGGCCCCAAAGGTGTTGACGGCTTACCTGGAGACATGGGGCCAC
CGGGGACTCCAGGTCGCCCGGGATTTAATGGCTTACCTGGGAACCCAGGTGTGCAGGGCCAGAAGGGAGAGCCTGGAGTTGGTCTACCGG
GACTCAAAGGTTTGCCAGGTCTTCCCGGCATTCCTGGCACACCCGGGGAGAAGGGGAGCATTGGGGTACCAGGCGTTCCTGGAGAACATG
GAGCGATCGGACCCCCTGGGCTTCAGGGGATCAGAGGTGAACCGGGACCTCCTGGATTGCCAGGCTCCGTGGGGTCTCCAGGAGTTCCAG
GAATAGGCCCCCCTGGAGCTAGGGGTCCCCCTGGAGGACAGGGACCACCGGGGTTGTCAGGCCCTCCTGGAATAAAAGGAGAGAAGGGTT
TCCCCGGATTCCCTGGACTGGACATGCCGGGCCCTAAAGGAGATAAAGGGGCTCAAGGACTCCCTGGCATAACGGGACAGTCGGGGCTCC
CTGGCCTTCCTGGACAGCAGGGGGCTCCTGGGATTCCTGGGTTTCCAGGTTCCAAGGGAGAAATGGGCGTCATGGGGACCCCCGGGCAGC
CGGGCTCACCAGGACCAGTGGGTGCTCCTGGATTACCGGGTGAAAAAGGGGACCATGGCTTTCCGGGCTCCTCAGGACCCAGGGGAGACC
CTGGCTTGAAAGGTGATAAGGGGGATGTCGGTCTCCCTGGCAAGCCTGGCTCCATGGATAAGGTGGACATGGGCAGCATGAAGGGCCAGA
AAGGAGACCAAGGAGAGAAAGGACAAATTGGACCAATTGGTGAGAAGGGATCCCGAGGAGACCCTGGGACCCCAGGAGTGCCTGGAAAGG
ACGGGCAGGCAGGACAGCCTGGGCAGCCAGGACCTAAAGGTGATCCAGGTATAAGTGGAACCCCAGGTGCTCCAGGACTTCCGGGACCAA
AAGGATCTGTTGGTGGAATGGGCTTGCCAGGAACACCTGGAGAGAAAGGTGTGCCTGGCATCCCTGGCCCACAAGGTTCACCTGGCTTAC
CTGGAGACAAAGGTGCAAAAGGAGAGAAAGGGCAGGCAGGCCCACCTGGCATAGGCATCCCAGGGCTGCGAGGTGAAAAGGGAGATCAAG
GGATAGCGGGTTTCCCAGGAAGCCCTGGAGAGAAGGGAGAAAAAGGAAGCATTGGGATCCCAGGAATGCCAGGGTCCCCAGGCCTTAAAG
GGTCTCCCGGGAGTGTTGGCTATCCAGGAAGTCCTGGGCTACCTGGAGAAAAAGGTGACAAAGGCCTCCCAGGATTGGATGGCATCCCTG
GTGTCAAAGGAGAAGCAGGTCTTCCTGGGACTCCTGGCCCCACAGGCCCAGCTGGCCAGAAAGGGGAGCCAGGCAGTGATGGAATCCCGG
GGTCAGCAGGAGAGAAGGGTGAACCAGGTCTACCAGGAAGAGGATTCCCAGGGTTTCCAGGGGCCAAAGGAGACAAAGGTTCAAAGGGTG
AGGTGGGTTTCCCAGGATTAGCCGGGAGCCCAGGAATTCCTGGATCCAAAGGAGAGCAAGGATTCATGGGTCCTCCGGGGCCCCAGGGAC
AGCCGGGGTTACCGGGATCCCCAGGCCATGCCACGGAGGGGCCCAAAGGAGACCGCGGACCTCAGGGCCAGCCTGGCCTGCCAGGACTTC
CGGGACCCATGGGGCCTCCAGGGCTTCCTGGGATTGATGGAGTTAAAGGTGACAAAGGAAATCCAGGCTGGCCAGGAGCACCCGGTGTCC
CAGGGCCCAAGGGAGACCCTGGATTCCAGGGCATGCCTGGTATTGGTGGCTCTCCAGGAATCACAGGCTCTAAGGGTGATATGGGGCCTC
CAGGAGTTCCAGGATTTCAAGGTCCAAAAGGTCTTCCTGGCCTCCAGGGAATTAAAGGTGATCAAGGCGATCAAGGCGTCCCGGGAGCTA
AAGGTCTCCCGGGTCCTCCTGGCCCCCCAGGTCCTTACGACATCATCAAAGGGGAGCCCGGGCTCCCTGGTCCTGAGGGCCCCCCAGGGC
TGAAAGGGCTTCAGGGACTGCCAGGCCCGAAAGGCCAGCAAGGTGTTACAGGATTGGTGGGTATACCTGGACCTCCAGGTATTCCTGGGT
TTGACGGTGCCCCTGGCCAGAAAGGAGAGATGGGACCTGCCGGGCCTACTGGTCCAAGAGGATTTCCAGGTCCACCAGGCCCCGATGGGT
TGCCAGGATCCATGGGGCCCCCAGGCACCCCATCTGTTGATCACGGCTTCCTTGTGACCAGGCATAGTCAAACAATAGATGACCCACAGT
GTCCTTCTGGGACCAAAATTCTTTACCACGGGTACTCTTTGCTCTACGTGCAAGGCAATGAACGGGCCCATGGCCAGGACTTGGGCACGG
CCGGCAGCTGCCTGCGCAAGTTCAGCACAATGCCCTTCCTGTTCTGCAATATTAACAACGTGTGCAACTTTGCATCACGAAATGACTACT
CGTACTGGCTGTCCACCCCTGAGCCCATGCCCATGTCAATGGCACCCATCACGGGGGAAAACATAAGACCATTTATTAGTAGGTGTGCTG
TGTGTGAGGCGCCTGCCATGGTGATGGCCGTGCACAGCCAGACCATTCAGATCCCACCGTGCCCCAGCGGGTGGTCCTCGCTGTGGATCG
GCTACTCTTTTGTGATGCACACCAGCGCTGGTGCAGAAGGCTCTGGCCAAGCCCTGGCGTCCCCCGGCTCCTGCCTGGAGGAGTTTAGAA
GTGCGCCATTCATCGAGTGTCACGGCCGTGGGACCTGCAATTACTACGCAAACGCTTACAGCTTTTGGCTCGCCACCATAGAGAGGAGCG
AGATGTTCAAGAAGCCTACGCCGTCCACCTTGAAGGCAGGGGAGCTGCGCACGCACGTCAGCCGCTGCCAAGTCTGTATGAGAAGAACAT
AATGAAGCCTGACTCAGCTAATGTCACAACATGGTGCTACTTCTTCTTCTTTTTGTTAACAGCAACGAACCCTAGAAATATATCCTGTGT
ACCTCACTGTCCAATATGAAAACCGTAAAGTGCCTTATAGGAATTTGCGTAACTAACACACCCTGCTTCATTGACCTCTACTTGCTGAAG
GAGAAAAAGACAGCGATAAGCTTTCAATAGTGGCATACCAAATGGCACTTTTGATGAAATAAAATATCAATATTTTCTGCAATCCAATGC
ACTGATGTGTGAAGTGAGAACTCCATCAGAAAACCAAAGGGTGCTAGGAGGTGTGGGTGCCTTCCATACTGTTTGCCCATTTTCATTCTT
GTATTATAATTAATTTTCTACCCCCAGAGATAAATGTTTGTTTATATCACTGTCTAGCTGTTTCAAAATTTAGGTCCCTTGGTCTGTACA
AATAATAGCAATGTAAAAATGGTTTTTTGAACCTCCAAATGGAATTACAGACTCAGTAGCCATATCTTCCAACCCCCCAGTATAAATTTC
TGTCTTTCTGCTATGTGTGGTACTTTGCAGCTGCTTTTGCAGAAATCACAATTTTCCTGTGGAATAAAGATGGTCCAAAAATAGTCAAAA
ATTAAATATATATATATATTAGTAATTTATATAGATGTCAGCAATTAGGCAGATCAAGGTTTAGTTTAACTTCCACTGTTAAAATAAAGC
TTACATAGTTTTCTTCCTTTGAAAGACTGTGCTGTCCTTTAACATAGGTTTTTAAAGACTAGGATATTGAATGTGAAACATCCGTTTTCA
TTGTTCACTTCTAAACCAAAAATTATGTGTTGCCAAAACCAAACCCAGGTTCATGAATATGGTGTCTATTATAGTGAAACATGTACTTTG
AGCTTATTGTTTTTATTCTGTATTAAATATTTTCAGGGTTTTAAACACTAATCACAAACTGAATGACTTGACTTCAAAAGCAACAACCTT
AAAGGCCGTCATTTCATTAGTATTCCTCATTCTGCATCCTGGCTTGAAAAACAGCTCTGTTGAATCACAGTATCAGTATTTTCACACGTA
AGCACATTCGGGCCATTTCCGTGGTTTCTCATGAGCTGTGTTCACAGACCTCAGCAGGGCATCGCATGGACCGCAGGAGGGCAGATTCGG
ACCACTAGGCCTGAAATGACATTTCACTAAAAGTCTCCAAAACATTTCTAAGACTACTAAGGCCTTTTATGTAATTTCTTTAAATGTGTA
TTTCTTAAGAATTCAAATTTGTAATAAAACTATTTGTATAAAAATTAAGCTTTTATTAATTTGTTGCTAGTATTGCCACAGACGCATTAA
AAGAAACTTACTGCACAAGCTGCTAATAAATTTGTAAGCTTTGCAAAAAAAAAAAAAGGAAAAAAGAAAGGAAAGAAAAGAAGAAAACCC
CTCTTCTGGCTCCAGGAAACAAGCTTCAACCCATTGCACACACCGGAGAAGGGGTTTCCCCCTGCCCGCCCGCCCGCCCCCCAACTACCT
CCCCGCTCCTGCCAGTGTCTGCCTCTCTGCCCCCACGGGGGTTTATTTGATCTCACATTAACCAAGGAGGAGAATGTGAGAAAAGGGGGA
AAATGCCCAGGAGGAAGCAGGAGCAGCCCAAGCGCCTTCCCTCACATGTTAGTAGGCAGGAAGAGGCGGAGGGAGAGCTCAGTGAAGGAG
AACACTGGTATGGAAACTCTTCAGAGACTCCGTCAGAAGCATCCTATGGGGAAGTCCAGGAGAACTATAAGTTGTCTCTGGAGGACCGGA
TCCAGGAGCAGTCCACGTCCCCGGACACCTCCTTGGGAAGCACGACTCCCAGCAGCCACACGTTGGAGCTGGTGGCACTGGACAGTGAGG
TCCTGCGAGACTCACTGCAGTGTCAAGATCACCTTTCCCCGGGAGTGTCTTCTTTGTGTGACGATGACCCAGGCTCCAACAAGCCCCTGA
GCAGCAATTTGAGGCGGCTGCTGGAGGCTGGTTCCCTCAAACTCGATGCTGCAGCCACGGCTAATGGCAGAGTGGAGTCCCCCGTAAACG
TTGGCTCGAACCTCTCCTTTTCCCCGCCTTCCCACCACGCCCAGCAGCTCAGTGTTCTGGCCAGGAAGTTGGCCGAGAAGCAGGAACAGA
ATGACCAATACACTCCAAGTAACCGTTTTATATGGAATCAAGGTAAGTGGTTGCCAAACTCAACCACCACCTGCAGCTTGTCTCCGGATT
CAGCCATCCTAAAACTGAAAGCTGCAGCCAATGCCGTTCTGCAGGACAAATCTCTCACCAGGACTGAGGAGACCATGCGATTTGAGTCCT
TTTCCTCCCCTTTTAGCTCCCAGTCTGCCAGTTCTACCTTGGCCGCTTTGTCCAAGAAGGTCAGTGAAAGAAGTTTGACTCCTGGTCAGG
AGCACCCTCCACCGGCCAGCTCCTTCCTTTCCCTGGCTTCTATGACCTCCTCAGCGGCCCTTCTGAAGGAGGTGGCCGCAAGGGCTGCGG
GCAGTCTTCTGGCTGAGAAATCATCGCTGCTGCCTGAGGACCCTCTACCGCCCCCGCCTTCAGAGAAGAAACCAGAAAAAGTCACTCCGC
CACCTCCACCGCCACCTCCACCACCTCCACCACCACCACCACAATCCCTGGAATTATTATTACTCCCAGTTCCTAAGGGAAGAGTTTCTA
AACCCTCCAATTCAGCCTCAGAAGAGGAAAGTGGAAAGCCTTTCCAGTGTCCAATATGTGGTTTGGTTATTAAAAGGAAGAGTTACTGGA
AGCGGCACATGGTGATTCACACAGGTTTAAAAAGTCATCAGTGTCCGCTCTGTCCATTCCGGTGTGCTCGCAAGGACAATCTCAAATCCC
ACATGAAGGTTCATCAGCACCAGGATCGGGGAGAGACCTTTCAGTGCCAGCTGTGCCCTTTTACTTCCTCACGCCACTTCAGCCTGAAAC
TCCACATGCGTTGCCATCAGCACTTCCTGAGGACAGAAGCCAAGGTGAAGGAGGAGATCCCAGACCCAGATGTCAAGGGATCTCCCCACC
TCAGTGACAGTGCCTGCCTGGGGCAGCAAAGGGAAGGAGGAGGGACAGAGCTAGTGGGGACCATGATGACGTCTAACACTCCAGAGAGGA
CTAGCCAGGGAGGGGCTGGCGTCTCGCCTTTGCTGGTGAAGGAGGAACCCAAGGAAGATAACGGCCTGCCCACCTCCTTTACTTTGAATG
CTGCCGACAGGCCCGCCAACCACACAAAGCTGAAAGACCCCTCCGAGTATGTGGCCAACAGTGCGTCAGCATTGTTCAGCCAGGACATCT
CTGTTAAGATGGCGTCTGATTTTCTCATGAAGCTGTCAGCTGCAAATCAGAAGGAGCCCATGAATCTTAATTTTAAAGTGAAAGAGGAGC
CTAAGGAAGGGGAGTCCCTAAGCACGACTTTGCCTCGGTCCAGCTATGTGTTCAGCCCGGAATCTGAAGTGTCAGCCCCAGGCGTCTCTG
AGGACGCACTAAAGCCCCAGGAAGGGAAGGGAAGTGTGCTAAGGCGGGATGTGTCAGTCAAAGCAGCCTCTGAACTTCTCATGAAACTCT
CAGCGGAAAGCTACAAGGAAACACAGATGGTGAAGATTAAAGAGGAACCCATGGAGGTTGACATCCAGGACTCCCATGTCTCGATATCAC
CCAGCCGGAATGTTGGCTACAGCACTTTAATCGGGCGAGAGAAAACCGAACCCTTACAGAAGATGCCAGAGGGCAGAGTACCCCCAGAGA
GAAACCTCTTCAGTCAGGATATCTCTGTGAAAATGGCTTCCGAGCTCCTCTTTCAACTGTCAGAAAAAGTGAGCAAAGAGCACAATCATA
CAAAAGAAAACACCATCCGGACCACGACCAGCCCTTTCTTTTCAGAAGACACATTTAGACAATCACCATTCACCTCCAATTCAAAAGAAC
TGCTGCCCAGTGACTCCGTGCTGCACGGAAGAATATCAGCTCCAGAAACAGAAAAGATAGTCCTAGAGGCAGGAAATGGATTACCATCCT
GGAAATTCAATGACCAGCTTTTTCCCTGTGACGTGTGTGGGAAAGTGTTTGGCCGACAGCAGACATTGTCCCGACACCTCTCGCTGCACA
CAGAGGAAAGAAAATACAAATGCCACTTGTGCCCCTATGCTGCTAAGTGCCGTGCAAATCTGAACCAGCACTTGACCGTCCATTCCGTGA
AGCTGGTGAGTACAGACACCGAGGACATTGTCAGCGCCGTCACCTCTGAAGGCAGTGATGGGAAGAAACATCCTTATTATTACAGTTGTC
ACGTGTGTGGATTTGAGACCGAGCTCAATGTCCAGTTTGTCAGCCACATGTCACTCCACGTGGACAAGGAGCAGTGGATGTTTTCGATCT
GCTGCACTGCCTGCGACTTCGTCACCATGGAGGAAGCAGAGATAAAGACTCACATTGGCACCAAGCACACAGGGGAAGACAGGAAGACCC
CCAGCGAATCAAATAGCCCCTCTTCATCCTCCCTCTCAGCTCTGAGTGATTCAGCCAACAGCAAAGATGATTCAGATGGCTCCCAGAAAA
ACAAGGGCGGGAACAATCTGCTGGTCATCTCTGTCATGCCTGGGAGCCAGCCCTCACTGAACAGTGAGGAAAAGCCAGAGAAAGGGTTCG
AATGTGTTTTTTGCAACTTTGTCTGCAAGACGAAGAACATGTTTGAGCGTCATCTGCAGATACACCTCATCACCCGGATGTTTGAGTGTG
ATGTGTGCCACAAGTTCATGAAGACCCCCGAACAGCTGCTGGAGCATAAGAAATGCCACACTGTCCCCACCGGTGGGCTCAACTCAGGAC
AGTGGTGAGTTTCAGACTCCTCTAGGTGCCCATTCTGCATTTATTCCACCAACCGCCCCGCTGCCATGGAGTGCCACCTCAAGACCCACT
ACAAGATGGAGTACAAGTGCCGGATCTGCCAGACGGTGAAGGCCAACCAGCTGGAGCTGGAGACGCACACCCGGGAGCACCGCCTGGGCA
ACCACTACAAGTGCGACCAGTGCGGCTACCTGTCCAAGACCGCCAACAAGCTCATCGAGCACGTGCGCGTCCACACCGGGGAGCGGCCCT
TCCACTGTGACCAGTGCAGCTACAGCTGCAAGCGCAAGGACAATCTCAACCTGCACAAGAAGCTGAAGCACGCCCCACGCCAGACCTTCA
GCTGCGAAGAGTGCCTGTTCAAGACCACACACCCTTTCGTCTTCAGCCGCCACGTCAAGAAGCACCAGAGTGGGGACTGCCCCGAGGAGG
ACAAGAAGGGCCTGTGTCCAGCCCCCAAGGAACCGGCCGGCCCGGGGGCCCCGCTCCTGGTGGTCGGGAGCTCCCGGAATCTCCTGTCTC
CCCTGTCAGTTATGTCTGCCTCCCAGGCTCTGCAGACCGTGGCCCTGTCGGCAGCCCACGGCAGCAGCTCAGAGCCCAACCTGGCACTCA
AGGCTTTGGCCTTCAACGGCTCCCCTTTGCGCTTTGACAAGTACCGGAACTCAGATTTTGCCCATCTCATTCCCTTGACAATGTTATACC
CCAAGAACCACTTGGATCTCACATTCCACCCTCCCCGACCTCAGACTGCGCCTCCCAGCATCCCCTCACCCAAACACTCCTTCCTGGCCT
ATCTCGGACTGAGAGAAAGAGCAGAGACTGTCTGAGGGCAGCCATGTTCTGTACCAAAAACAGAGAGACAAAAGACAAAAAAAAAAAAAA
AAACCACAAAACTTAAACACAACCCCAGCAGGTGTATGTTGCTGCAAAACCTACAGACCCCGATGGGTCTGGAACATGTGTACTGTATAT
CTTTAGTAAGGAATAGAAAATTGGCTCTGTGTGTATACCTATTGCATTGACCTGAAAGCTGCTTTATCCAATCTTCAGAGAGGTGACCTA
CTGCATACTTCTACCTTCAGAGGCATGCCTCCCCAGCCACCCACTCCCACTCTCAGCCCTTCTCCGTACTTTTCTCTGAAAGGAATCTTG
TCTTGTTAAACCCTAAAGAGAGTGTCCTTAATAGCAATCAGCACTTGTAAGCTTATATACTGGTGCATTTGGTTTTCTGTTGGGTGAATG
CGGTGTGTGGGCGTTTGTGGATTCTGAAAGAGAAAGCCGTGTGTCGTGTGCCATGACATTTCTATTGCACATTCTTTGTACTGGCTTCTT
TAACAGCGATGAACGTTCTTTTCCCTCCTGGGTTGTTCATCCACGACAGTCTCTCCCTGTGCTCCTTCATCACCTTTCCCTCTCTCTTTG
ATGGCTACAGAGTGGTAGGGCCTGGTGCTTAGTCGATGAAGGAATGGTAGCCATCTACAGTGCTGCTGGAGATTTCCGCCAGAGCGCTGG
AGACCTTGCGCTCAGATCTTCTCTGGTGATGAAGAGGCGAGGAATCAAGTGACTGATCTGGAAGAAATATCTCGCAGCACTGCAGCTAAC
ATCACAGAACTTAAGTGTGTTTTGTGTGTGTGCCCACACGTAGACAAATGTGTACGGTGCACACACACAGTGCATCATTTTTTAAGGGCA
GATTATATATATATATGAGATGTATTAATTCAGTGGTTACCATTTGTTTGCAGGAAAAAGAAATGTATGGGTGAAAAAATTTATGGTTGA
TAAATCCAGCCAAGGAGATTAAAAGGGGTTTGGATAAATTCTGGGTATAAATGCTCAGACTAAAAAAAAGAAATGGCAGTTTTGCACAGT
GCTATGGTCTTGCACTAGTTTTTGTTTCTCATCTGAAAAAAAAAAAGTAAAATAAAAGGAAGAAAATGTACCTTTTTTATGGAATGAGTA
GACTGTATGTTTGAAGATTTAGCCACAACCTCTTTGACATATAATGACGCAACAAAAAGGTGCTGTTTAGTCCTATGGTTCAGTTTATGC
CCCTGACAAGTTTCCATTGTGTTTTGCCGATCTTCTGGCTAATCGTGGTATCCTCCATGTTATTAGTAATTCTGTATTCCATTTTGTTAA
CGCCTGGTAGATGTAACCTGCTAGGAGGCTAACTTTATACTTATTTAAAAGCTCTTATTTTGTGGTCATTAAAATGGCAATTTATGTGCA
GCACTTTATTGCAGCAGGAAGCAGGTGTGGGTTGGTTGTAAAGCTCTTTGCTAATCTTAAAAAGTAATGGGTGATTTAAAAAGAAAAAAG
GAAAAAAATCTTTGGCTGAATATGTTCATTGCTTGTATTTTTAAAACAACAGAATTTCCAGTATGAAACAGGCTGAAAGAGCAGGAAGAA
ATGTTCTTTGTATAATAATGGGAAGTTTGGAATATAAAAGTTTATATATTATTTATCTATTGGAGAACTGGTGTACAGGAGGAACATTTT
CTTACTGTGTTGCTGTTTTCCATCATGTGTTATCCTAAGAGTTGGGGTTTTTTAAAATCTGTTTCACCAGGGGAAAATAAAAGCATCCCT
AATGTTCTTCCTCTAGTCAGTTTGCTTTGCTGAAAGCTCCCTGGAAATTAGTACAGTTCTACAGGAAGCCAGAAGACTGTACTGTCTGTC
CACACCATGGTCTCCTCAGTCCCCTCCACGCCAGCCCCTCTTCCCCACACCTAGTAGGTGTGCTACACCTCCCTTTGCCAGTCATCCCGC
CATGGATGGGGAGCCTACTTGGTGCCCTGGCAAACCTGTTTACACTAAGGAGATGCCCACAGGGAGCGGGAAGCTCCCAAACCCTCAGTC
ATTCTCCAGCAGAGACCTTTGCTCTTGGCCAGGTTTGAAACGATGTTCAACCTCGCCACGTCAATGTCTCAGTAAAAGACACTATAGATA
GTTATGGACAATACACTCCAAGAATACTGGGCTTATGGGTGGGTTGGTTTTTTGTTTTGTTTTGTTTTGTTTTCAAGTCATGTCTTTATC
CCCATATAATGGAGAATGTGCCACTTGGCTAATAATGTGTTTTCAAAACTACAAGTTCAGTGATGACAGGAAAGAGGGCTAAAGTAGTCC
CACAGAGGCTGGTAGAAAAGGCGAATCACACTTAAGCACCAGCAGGTTAAAAACCTGAAAGGGTGGCCCTGACAATTCAGACTATAGGTT
TTACAGCATGCCACTTGTGCAATAGGAGGTCTAGGGTTGAAACTTTCAAGAACGAGAGGAGGTGAAGGAAGGAGACGTTTACTGCTCAAA
TGCCATGCATTTCACTGCTTGCCACTGAACTTGTATTTGAATGACTTAGTAATGCTTAATATAATTGGGCAACTTTTTTAGCACTTTGGA
AAGAGTCATCAATCTTTCTGGTAAATTATAAAAGTTTTCTGAGTGAGAAAAGGTGTGTTTGGAGTTTGTTTGACTTTTTATATTATTATT
GTTATTAATAAAGAAAAAAATCTACAGCATTTTTCAGACTCCACCCTAGAAAATATGTACCCCTGAATTTGGTTTGCAGTTTGATACTCA
GGGAAGGATGTATTCCATAGATATCCTTTCCGTATAAAACACTAACATCTTTGAGAAATTCACCTACCAACTAACTTCAATTGTTGTCAC
TATGCATTCTTCAATGAAAACTAGCTTATTTTTCCATATAGTAATGCAGTTAGGGTTCTCAGCACTTTCTTTCTTCTATCCTTTTTTTAA
CTCTTCATATTATGTTCAGATGATCATACTGTCAAGGTTTGTGTACATTACTGAAAATTTGTATTGTATAAAGCTTTTTGCATTACGAGG
CTGTACAGGGTCATTTTGACAGTAACTGGTATATTCCTTTGCATCTTATGTTGCATTGCCAATTTCTAGTGTATCCAGTTTGAAAGTATA

>18348_18348_1_COL4A1-ZNF827_COL4A1_chr13_110801311_ENST00000375820_ZNF827_chr4_146859787_ENST00000508784_length(amino acids)=1689AA_BP=
MSAAAPARRAAVPRRLGRATMGPRLSVWLLLLPAALLLHEEHSRAAAKGGCAGSGCGKCDCHGVKGQKGERGLPGLQGVIGFPGMQGPEG
PQGPPGQKGDTGEPGLPGTKGTRGPPGASGYPGNPGLPGIPGQDGPPGPPGIPGCNGTKGERGPLGPPGLPGFAGNPGPPGLPGMKGDPG
EILGHVPGMLLKGERGFPGIPGTPGPPGLPGLQGPVGPPGFTGPPGPPGPPGPPGEKGQMGLSFQGPKGDKGDQGVSGPPGVPGQAQVQE
KGDFATKGEKGQKGEPGFQGMPGVGEKGEPGKPGPRGKPGKDGDKGEKGSPGFPGEPGYPGLIGRQGPQGEKGEAGPPGPPGIVIGTGPL
GEKGERGYPGTPGPRGEPGPKGFPGLPGQPGPPGLPVPGQAGAPGFPGERGEKGDRGFPGTSLPGPSGRDGLPGPPGSPGPPGQPGYTNG
IVECQPGPPGDQGPPGIPGQPGFIGEIGEKGQKGESCLICDIDGYRGPPGPQGPPGEIGFPGQPGAKGDRGLPGRDGVAGVPGPQGTPGL
IGQPGAKGEPGEFYFDLRLKGDKGDPGFPGQPGMTGRAGSPGRDGHPGLPGPKGSPGSVGLKGERGPPGGVGFPGSRGDTGPPGPPGYGP
AGPIGDKGQAGFPGGPGSPGLPGPKGEPGKIVPLPGPPGAEGLPGSPGFPGPQGDRGFPGTPGRPGLPGEKGAVGQPGIGFPGPPGPKGV
DGLPGDMGPPGTPGRPGFNGLPGNPGVQGQKGEPGVGLPGLKGLPGLPGIPGTPGEKGSIGVPGVPGEHGAIGPPGLQGIRGEPGPPGLP
GSVGSPGVPGIGPPGARGPPGGQGPPGLSGPPGIKGEKGFPGFPGLDMPGPKGDKGAQGLPGITGQSGLPGLPGQQGAPGIPGFPGSKGE
MGVMGTPGQPGSPGPVGAPGLPGEKGDHGFPGSSGPRGDPGLKGDKGDVGLPGKPGSMDKVDMGSMKGQKGDQGEKGQIGPIGEKGSRGD
PGTPGVPGKDGQAGQPGQPGPKGDPGISGTPGAPGLPGPKGSVGGMGLPGTPGEKGVPGIPGPQGSPGLPGDKGAKGEKGQAGPPGIGIP
GLRGEKGDQGIAGFPGSPGEKGEKGSIGIPGMPGSPGLKGSPGSVGYPGSPGLPGEKGDKGLPGLDGIPGVKGEAGLPGTPGPTGPAGQK
GEPGSDGIPGSAGEKGEPGLPGRGFPGFPGAKGDKGSKGEVGFPGLAGSPGIPGSKGEQGFMGPPGPQGQPGLPGSPGHATEGPKGDRGP
QGQPGLPGLPGPMGPPGLPGIDGVKGDKGNPGWPGAPGVPGPKGDPGFQGMPGIGGSPGITGSKGDMGPPGVPGFQGPKGLPGLQGIKGD
QGDQGVPGAKGLPGPPGPPGPYDIIKGEPGLPGPEGPPGLKGLQGLPGPKGQQGVTGLVGIPGPPGIPGFDGAPGQKGEMGPAGPTGPRG
FPGPPGPDGLPGSMGPPGTPSVDHGFLVTRHSQTIDDPQCPSGTKILYHGYSLLYVQGNERAHGQDLGTAGSCLRKFSTMPFLFCNINNV
CNFASRNDYSYWLSTPEPMPMSMAPITGENIRPFISRCAVCEAPAMVMAVHSQTIQIPPCPSGWSSLWIGYSFVMHTSAGAEGSGQALAS

--------------------------------------------------------------

Top

Fusion Gene PPI Analysis for COL4A1-ZNF827


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for COL4A1-ZNF827


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

Related Diseases for COL4A1-ZNF827


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneCOL4A1C4551998Porencephaly, Type 1, Autosomal Dominant18CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneCOL4A1C2673195Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps6CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneCOL4A1C1843512BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE4CTD_human;GENOMICS_ENGLAND;ORPHANET
HgeneCOL4A1C0018965Hematuria3GENOMICS_ENGLAND
HgeneCOL4A1C0266548Axenfeld anomaly (disorder)3CTD_human;GENOMICS_ENGLAND
HgeneCOL4A1C1860475Retinal vascular tortuosity3GENOMICS_ENGLAND
HgeneCOL4A1C0011881Diabetic Nephropathy2CTD_human
HgeneCOL4A1C0017667Nodular glomerulosclerosis2CTD_human
HgeneCOL4A1C0017668Focal glomerulosclerosis2CTD_human
HgeneCOL4A1C0086432Hyalinosis, Segmental Glomerular2CTD_human
HgeneCOL4A1C0265341Rieger syndrome2CTD_human
HgeneCOL4A1C0266484Schizencephaly2CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneCOL4A1C0302892Congenital porencephaly2CTD_human
HgeneCOL4A1C1280768Axenfeld syndrome2CTD_human
HgeneCOL4A1C1867983PORENCEPHALY, FAMILIAL2CTD_human;ORPHANET
HgeneCOL4A1C2675650Brain Small Vessel Disease With Axenfeld-Rieger Anomaly2CTD_human
HgeneCOL4A1C2678503AXENFELD-RIEGER SYNDROME, TYPE 32CTD_human
HgeneCOL4A1C3281105HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO2GENOMICS_ENGLAND;UNIPROT
HgeneCOL4A1C3495488Axenfeld-Rieger syndrome2CTD_human
HgeneCOL4A1C3698507Post-traumatic Porencephaly2CTD_human
HgeneCOL4A1C3714873Axenfeld-Rieger Syndrome, Type 12CTD_human
HgeneCOL4A1C4082173Porencephaly2CTD_human
HgeneCOL4A1C4082301Developmental Porencephaly2CTD_human
HgeneCOL4A1C0002878Anemia, Hemolytic1CTD_human
HgeneCOL4A1C0002879Anemia, Hemolytic, Acquired1CTD_human
HgeneCOL4A1C0002889Anemia, Microangiopathic1CTD_human
HgeneCOL4A1C0015393Eye Abnormalities1CTD_human
HgeneCOL4A1C0023893Liver Cirrhosis, Experimental1CTD_human
HgeneCOL4A1C0026848Myopathy1GENOMICS_ENGLAND
HgeneCOL4A1C0027726Nephrotic Syndrome1CTD_human
HgeneCOL4A1C0036572Seizures1GENOMICS_ENGLAND
HgeneCOL4A1C0038454Cerebrovascular accident1GENOMICS_ENGLAND
HgeneCOL4A1C0149931Migraine Disorders1GENOMICS_ENGLAND
HgeneCOL4A1C0221021Microangiopathic hemolytic anemia1CTD_human
HgeneCOL4A1C0265221Walker-Warburg congenital muscular dystrophy1ORPHANET
HgeneCOL4A1C0270612Leukoencephalopathy1CTD_human
HgeneCOL4A1C0338656Impaired cognition1GENOMICS_ENGLAND
HgeneCOL4A1C0424605Developmental delay (disorder)1GENOMICS_ENGLAND
HgeneCOL4A1C0497327Dementia1GENOMICS_ENGLAND
HgeneCOL4A1C0557874Global developmental delay1GENOMICS_ENGLAND
HgeneCOL4A1C1135196Heart Failure, Diastolic1CTD_human
HgeneCOL4A1C1858991Childhood Ataxia with Central Nervous System Hypomyelinization1CTD_human
HgeneCOL4A1C1867327RETINAL ARTERIES, TORTUOSITY OF1CTD_human;ORPHANET;UNIPROT
HgeneCOL4A1C2733158Cerebral Small Vessel Diseases1GENOMICS_ENGLAND
HgeneCOL4A1C2930808Familial vascular leukoencephalopathy1ORPHANET
HgeneCOL4A1C2931870Familial schizencephaly1ORPHANET
HgeneCOL4A1C4013035BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES1GENOMICS_ENGLAND